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Abstract
Exposure to cigarette smoking affects the epigenome and could increase the risk of devel-
oping diseases such as cancer and cardiovascular disorders. Changes in DNA methylation
associated with smoking may help to identify molecular pathways that contribute to disease
etiology. Previous studies are not completely concordant in the identification of differentially
methylated regions in the DNA of smokers. We performed an epigenome-wide DNAmethyl-
ation study in a group of monozygotic (MZ) twins discordant for smoking habits to determine
the effect of smoking on DNAmethylation. As MZ twins are considered genetically identical,
this model allowed us to identify smoking-related DNA methylation changes independent
from genetic components. We investigated the whole blood genome-wide DNA methylation
profiles in 20 MZ twin pairs discordant for smoking habits by using the Illumina Human-
Methylation450 BeadChip. We identified 22 CpG sites that were differentially methylated
between smoker and non-smoker MZ twins by intra-pair analysis. We confirmed eight loci
already described by other groups, located in AHRR, F2RL3,MYOG1 genes, at 2q37.1 and
6p21.33 regions, and also identified several new loci. Moreover, pathway analysis showed
an enrichment of genes involved in GTPase regulatory activity. Our study confirmed the evi-
dence of smoking-related DNA methylation changes, emphasizing that well-designed MZ
twin models can aid the discovery of novel DNA methylation signals, even in a limited sam-
ple population.
Introduction
The term “epigenetics” refers to heritable changes in gene function, which do not involve
changes to the underlying DNA sequence; a change in phenotype without a change in geno-
type. Epigenetic changes arising during a lifetime are likely to be triggered by individual endog-
enous factors as well as by environmental factors. Given the central role played by the
progressive accumulation of epigenetic changes in the etiopathology of cancer and other de-
generative diseases [1], there is growing interest in the effect of modification on disease risk
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exerted by environmental and lifestyle factors, which may ultimately alter the risk of develop-
ing cancer. Among lifestyle and behavioral factors, smoking habits deserve major consider-
ation. In fact, epigenetic alterations are likely to play a role in tobacco-induced cancers; an
association between smoking and altered DNAmethylation of specific genes in lung cancer tis-
sue has been shown [2], as well as the progressive accumulation of epigenetic alterations in the
respiratory epithelium of heavy smokers during the carcinogenic process [3, 4]. In addition, re-
cent epigenome-wide association studies identified several genetic loci showing smoking-relat-
ed DNA methylation changes in DNA from blood [3, 5–10], supporting the use of this
surrogate non-tumor tissue to detect altered DNA methylation in smokers.
Monozygotic (MZ) twins provide a powerful model to assess the influence of environmental
factors on a particular trait of interest; in subjects who are genetically identical but experience
different exposure to environmental or lifestyle factors, any differences can be directly ascribed
to this non-shared environment experienced by co-twins [11, 12]. Thus, genetically identical
individuals can provide a convenient model to evaluate epigenetic changes where there is no
genetic variation.
Taking advantage of the MZ twin-based design, we investigated the effects of smoke expo-
sure on genomic DNAmethylation in a population of co-twins with discordant smoking habits
[13].
The use of MZ twin pairs who were discordant for smoking habits allowed a perfect match
both for the genetic component and the in utero and early childhood environmental exposures
between smoker and non-smoker co-twins, thus greatly increasing the sensitivity of the analy-
sis. In the present investigation we tested, on a genome-wide level, whether smoking duration
and/or intensity could modulate gene-specific methylation in blood DNA.
Material and Methods
Sample description
A total of 21 MZ twin pairs who were discordant for smoking habits were enrolled in this
cross-sectional study, which was conducted in accordance with the principles of Good Clinical
Practice and approved by the Independent Ethics Committee of the University of Rome ‘‘Tor
Vergata”. Written informed consent was obtained from all subjects according to the Declara-
tion of Helsinki. Information on demographics, medical history, lifestyle, dietary habits, occu-
pational and environmental exposures was collected by means of a questionnaire. Saliva
samples were taken from all subjects to verify the zygosity status. Testing for zygosity was per-
formed using the AmpFiSTRs Identifier kit (Applied Biosystems) [13]. All analyses were car-
ried out on coded samples.
Smoking history
Detailed information on smoking history was collected for all subjects as previously described
[13, 14]. Smoking status was assigned as follows: a) smokers: each member of the MZ twin pair
that smoked; all smokers had a tar intake of 60 mg tar/day, based on the number of cigarettes
smoked per day multiplied by the tar yield of the cigarette brand as declared on the pack (this
cut-off was chosen to exclude irregular or occasional smokers); b) non-smokers: each member of
the MZ twin pair who has never smoked or had stopped smoking since more than 10 years. To
avoid misclassifications based on the self-reported smoker or non-smoker status, urinary cotin-
ine levels were measured in all study subjects using the Accutest NicAlert_test kit (Jant Pharma-
cal Corp.) according to the manufacturer’s instructions. Overall tobacco exposure during tha
smoker’s lifetime was quantified by the pack-year parameter which integrates the number of cig-
arettes smoked per day during the smoking period. In particular, one pack-year is defined as 20
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manufactured cigarettes (one pack) smoked per day for one year, and the number of pack-years
for each smoker was calculated as (number of cigarettes smoked per day × number of years
smoked)/20.
Blood sample collection
Blood samples from all donors were collected within 2 days. Members of the same twin-pair
were sampled on the same day, and blood samples were processed in parallel. Differential
white blood cells (WBCs) count was determined for each sample, as previously described [13].
DNAmethylation array
Genomic DNA was isolated from whole blood samples using Puregene Core Kit (Qiagen, Hil-
den, Germany), according to the manufacturer’s instructions and stored at −80°C. Bisulphite
conversion of 500 ng of each sample was performed using the EZ-96 DNAMethylation Gold
kit (Zymo Research, Orange, CA, USA). Bisulphite-converted DNA was hybridized on the Illu-
mina HumanMethylation450 BeadChip (Illumina Inc., San Diego, CA), following the Illumina
Infinium HDmethylation protocol.
Statistical analyses
The GenomeStudio Methylation Module v1.0 software (Illumina) was used to convert on-chip
fluorescent methylation signals into numerical values (β-values) between 0 and 1, which repre-
sent the methylation percentage of each analyzed CpG site.
Raw methylation data were normalized and analyzed according to standard procedures
using the open source R statistical environment Bioconductor (methylumi package) [15]. The
following criteria were used to filter out samples, β-values, and CpG sites respectively: global
call rate 95%, detection p-value 0.01, and detection p-value  0.01 in more than 20% of
the assayed samples. To identify differentially methylated CpGs between smokers and non-
smokers, we applied the paired Kruskal-Wallis non parametric test. CpG loci with p<0.001,
and mean methylation differences of at least 0.03 and greater than 3 standard deviations from
the mean were selected and further investigated. In order to ascertain whether inter-individual
variability in whole blood cell composition could affect the results, for each of the identified dif-
ferentially methylated sites we compared the estimated differences in methylation by two mul-
tivariate linear regression models: the first including cell type composition (from each subject’s
WBC count) as covariate, and the second without adjusting for cell type.
To investigate the association between time and smoking intensity with DNA-methylation
levels of the CpG sites identified in the previous analysis, Spearman correlation coefficients be-
tween intra-pair differences (non-smokers vs smokers) in methylation and pack-years were
calculated.
Enrichment analysis
Enrichment analysis was carried out using the Gene Ontology (GO) tool “WEB-based GEne
SeT AnaLysis Toolkit” (WebGestalt; http://bioinfo.vanderbilt.edu/webgestalt/; [16, 17]). A list
of 223 genes in which the top differentially methylated CpGs between smokers and non-smok-
ers were located (p<0.001; S1 Table) was uploaded, 216 of which were recognized by the soft-
ware and analyzed.
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Results
The final dataset included 20 twin pairs. A total of 436,184 CpG sites passed the quality control,
22 of which (Table 1; CpG list ordered by Mean Δβ) had differential methylation levels associ-
ated with smoking status (selected as described in the Materials and Methods section). No sig-
nificant difference was observed comparing DNAmethylation between smokers and non-
Table 1. DNAmethylation differences at specific loci between smoking and non-smoking discordant twin pairs.
ProbeID Chr Position Gene Mean
Δβ
SD p-value Previously reported
cg05575921 5 373378 AHRR -0.140 0.018 1.91x10-
6
Besingi and Johansson 2014; Breitling et al. 2011; Dogan et al. 2014; Elliott
et al. 2014; Harlid et al. 2014; Monick et al. 2012; Shenker et al. 2013;
Zeilinger et al. 2013
cg21566642 2 233284661 -0.088 0.015 4.77x10-
5
Monick et al. 2012 (lung macrophages); Shenker et al. 2013; Zeilinger et al.
2013
cg05951221 2 233284402 -0.073 0.013 5.72x10-
6
Monick et al. 2012 (lung macrophages); Harlid et al. 2014; Shenker et al.
2013
cg06126421 6 30720080 -0.062 0.010 2.10x10-
4
Besingi and Johansson 2014; Dogan et al. 2014; Elliott et al. 2014; Shenker
et al. 2013; Zeilinger et al. 2013
cg01940273 2 233284934 -0.060 0.011 5.72x10-
6
Shenker et al. 2013; Zeilinger et al. 2013
cg01961092 4 84373320 HELQ -0.047 0.006 4.83x10-
4
cg03636183 19 17000585 F2RL3 -0.046 0.009 1.91x10-
5
Besingi and Johansson 2014; Harlid et al. 2014; Shenker et al. 2013; Wan
et al. 2012; Zeilinger et al. 2013
cg25648203 5 395444 AHRR -0.042 0.007 8.20x10-
5
Breitling et al. 2011; Shenker et al. 2013; Zeilinger et al. 2013; Monick et al.
2012 (lung macrophages)
cg13437870 6 52909126 ICK -0.040 0.007 4.83x10-
4
cg04074536 4 798711 CPLX1 -0.038 0.009 5.86x10-
4
cg03650233 8 57360226 PENK -0.038 0.007 7.08x10-
4
cg12224879 2 46973883 SOCS5 -0.037 0.005 2.61x10-
4
cg09022230 7 5457225 TNRC18 -0.037 0.008 3.22x10-
4
cg10655371 7 91749682 CYP51A1 -0.036 0.007 5.86x10-
4
cg26979044 16 25045552 -0.036 0.006 1.68x10-
4
cg02339888 1 67862336 IL12RB2 -0.034 0.006 4.83x10-
4
cg08681409 10 134697042 -0.032 0.007 2.10x10-
4
cg23261204 10 133733416 -0.032 0.004 4.83x10-
4
cg02567879 1 11761416 C1orf187 -0.030 0.007 3.95x10-
4
cg01157780 20 34700376 EPB41L1 0.031 0.006 1.05x10-
4
cg06935361 13 32964454 BRCA2 0.049 0.006 7.08x10-
4
cg12803068 7 45002919 MYO1G 0.083 0.013 3.95x10-
4
Zeilinger et al. 2013
doi:10.1371/journal.pone.0128265.t001
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smokers with and without adjusting for WBC proportions, thus we described the results ob-
tained without any adjustment for WBC count.
Out of the 22 CpGs with differential methylation levels, 15 were located in known genes.
The majority of these CpGs (86%) were found to be less methylated in smokers. The most sig-
nificant CpG site, cg05575921 (Δ smokers vs non-smokers -14%, p = 1.91x10-6), was located in
the AHRR gene. The second region was on chromosome 2q37.1 and comprised three differen-
tially methylated CpG sites (Δ smokers vs non-smokers: cg21566642–8.8%, p = 4.77x10-5;
cg233284402–7.3%, p = 5.72x10-6; cg233284934–6%, p = 5.72x10-6, respectively).
The intergenic region at 6p21.33 was located in a gene desert region and included the CpG
locus cg06126421, which is less methylated in smokers than in non-smokers (Δ smokers vs
non-smokers = -6.2%, p = 2.10x10-4).
We found DNA hypomethylation in smokers in the cg01961092 site, located in theHELQ
gene body (Δ smokers vs non-smokers = -4.7%, p = 4.83x10-4) and we also report a significant
association of tobacco smoking with the CpG site cg03636183, located within the F2RL3 gene
(Δ smokers vs non-smokers = -4.6%, p = 1.91x10-5).
Other hypomethylated sites in smokers with a difference> 3% were located in the following
genes: ICK, CPLX1, PENK, SOCS5, TNRC18, CYP51A1 and IL12RB2 or in regions with no an-
notated transcripts.Three sites resulted as being hypermethylated in smokers, which were lo-
cated in theMYO1G (cg12803068), BRCA2 (cg06935361) and EPB41L1 (cg01157780) genes.
Moreover, a positive correlation between methylation Δs (as described in the Materials and
Methods section) and smoking intensity (expressed as pack-years) was found for three of the
above mentioned loci: 2q37.1, EPB41L1 andMYO1G (Fig 1).
For the gene-set enrichment analysis, a list of 223 genes in which CpGs differentially methyl-
ated between smokers and non-smokers were found to be located (S1 Table) was considered,
216 of which were recognized byWebGestalt software and analyzed for GO enrichment analysis.
A total of six molecular function categories (Table 2) were significantly enriched (FDR q-value
>0.05). The most enriched molecular function categories were all related to GTPase regulatory
activity; in particular the Rho- and Ras-guanyl-nucleotide exchange factor activity categories
were the most enriched (FDR q-value = 0.0158 for both). The genes harboring differentially
methylated CpGs that were classified as members of the “small GTPase regulator activity”, “Rho
guanyl-nucleotide exchange factor activity” and “Ras guanyl-nucleotide exchange factor activity”
Fig 1. Correlation betweenmethylation levels and smoking intensity (expressed as pack-years) for 2q37.1, EPB41L1 andMYO1G loci.
doi:10.1371/journal.pone.0128265.g001
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categories were: PSD4, TBC1D22A,MCF2L, RASGRF2, IQSEC1, KALRN, OBSCN, DENND3,
ARHGEF16.
Discussion
In order to investigate gene-specific DNAmethylation changes associated with smoking habits
we used a high-throughput whole-genome approach in a sample of MZ twins discordant for
smoking habits. Comparing discordant MZ twins represents a powerful improvement over the
traditional case-control study to search for disease-associated biological markers and environ-
mental exposure-related phenotypes. The strength of this design to unveil epigenetic effects
was demonstrated in recent studies which compared the DNA methylation patterns of MZ
twins who were discordant for various diseases [18–22]. Direct comparisons between identical
twins constitute an ideal experimental model for testing environmental epigenetics because dif-
ferences in DNA sequences, including single-nucleotide polymorphisms (SNPs) abundant in
singleton-based studies, which could potentially modulate the effects of environmental expo-
sures or the DNA methylation levels, do not interfere in the analysis.
Several of the most significant smoking-associated hypomethylated CpG sites that we have
described here have been already reported in the literature (see Table 1).
The underlying relationship of AHRR hypomethylation and smoking is further supported
by Monick et al. [23], who reported a significant association between cg05575921 DNA meth-
ylation and AHRR gene expression and by Philibert et al. [24], showing a high correlation of
AHRR DNAmethylation and serum cotinine levels in smokers. The latter concluded that
AHRR DNAmethylation status is a sensitive marker of smoking history, which could help
with integrating self-reported smoking habits or existing smoking-related biomarkers used in
clinical or epidemiological settings (e.g., cotinine). In addition, if properly configured as a clini-
cal assay, AHRRmethylation levels could also be used as a screening tool in efforts to target an-
tismoking interventions to nascent smokers in the early phases of smoking.
We found a novel CpG hypomethylated in smokers (cg01961092) located in theHELQ gene
body. HELQ is a 3’–5’ DNA helicase with strand displacement activity that was recently shown
Table 2. Gene enrichment results carried out using the Gene Ontology (GO) enrichment analysis web-based bioinformatics tool WEB-based GEne
SeT AnaLysis Toolkit (WebGestalt).
Molecular functions that were enriched for genes differentially methylated in smokers
GO Term Description p-value FDR q-
value
Genes
GO:0005083 small GTPase regulator activity 0.0004 0.0158 PSD4, TBC1D22A, MCF2L, RASGRF2, IQSEC1, KALRN, OBSCN,
DENND3, ARHGEF16




0.0158 PSD4, MCF2L, RASGRF2, IQSEC1, KALRN, OBSCN, DENND3,
ARHGEF16
GO:0005089 Rho guanyl-nucleotide exchange
factor activity
0.0005 0.0158 MCF2L, RASGRF2, KALRN, OBSCN, ARHGEF16
GO:0005088 Ras guanyl-nucleotide exchange
factor activity
0.0003 0.0158 MCF2L, RASGRF2, KALRN, OBSCN, DENND3, ARHGEF16
GO:0005543 phospholipid binding 0.0005 0.0158 IRS2, DOC2A, SH3BP2, PSD4, MCF2L, RASGRF2, OSBPL5, IQSEC1,
OBSCN, KALRN, APOA1, ARHGEF16
GO:0070644 vitamin D response element
binding
0.0004 0.0158 TCF3, RXRA
Cellular components that were enriched for genes differentially methylated in smokers
GO Term Description p-value FDR q-
value
Genes
GO:0017053 transcriptional repressor complex 0.0003 0.0483 TFAP4, NCOR2, ZFPM1, PRDM16, MTA1
doi:10.1371/journal.pone.0128265.t002
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to participate in resistance to the DNA interstrand crosslinking pathway [25], caused also by al-
dehydes such as acrolein and crotonaldehyde, found in tobacco smoke [26].
The F2RL3 (coagulation factor II receptor-like 3) gene encodes for a protease-activated re-
ceptor-4 (PAR-4), which has been suggested to be involved in the pathophysiology of both car-
diovascular and neoplastic diseases. These patterns suggest that the adverse health effects of
smoking could be partly mediated by pathways through F2RL3methylation. Recently Zhang
et al., showed that F2RL3methylation intensity is strongly correlated with smoking status [27]
and is a predictor of smoking-related mortality [28].
No clear biological relationships between smoking and other identified genes (CPLX1,
PENK, SOCS5, IL12RB2, CYP51A1, TNRC18, ICK) are evident, however some of these genes
have been previously reported as smoking-associated.
We also found CpG loci with higher DNAmethylation levels in smokers located in the
MYO1G, BRCA2 and EPB41L1 genes (Table 1).
TheMYO1G cg12803068 site and other CpGs in the same gene have been already described
as hypermethylated in smokers in previous studies [7, 9, 29]. MYO1G is a plasma membrane-
associated class I myosin that is abundant in T and B lymphocytes and mast cells [30], and con-
tributes to cell elasticity [31]. Altered expression ofMYO1G could contribute in explaining the
increased fibrosis found in several smoking-targeted tissues.
None of the reported differentially methylated loci reached a Bonferroni-corrected p-value
threshold (p = 1.15x10-7). However, this statistical correction is likely to be too conservative
given the non-independence of CpG sites and the identical MZ twin intra-pair genetic back-
ground. In view of the above considerations, in order to identify differentially methylated loci,
we used a combined analytical approach which took into account both the statistical signifi-
cance (with p<0.001 as an arbitrary threshold) and the extent of methylation changes (SD and
mean β-value differences). This analytical approach is widely used in genome-wide gene ex-
pression studies, and is reported to identify loci with high reproducibility and biological rele-
vance compared with conventional methods that merely rely on single CpG statistical
significance. Moreover, the usefulness of this approach is supported by the identification (also
in our study) of differentially methylated loci already described in association with smoking,
showing the same methylation trends as those previously reported.
MZ twins provide a valuable model to identify environmental effects without the influence
of genetic variability. Nevertheless, given the relatively small sample size, replication of our
newly identified results in larger samples is needed.
The difference we observed in AHRRmean methylation levels (14%, range 1–32%) between
smokers and non-smokers was comparable with those reported in larger non-twin indepen-
dent populations studied by other authors (17% in [3]; 24.4% in [29]; 7.4% in [9]; 15% in [8];
22% in [7]). However, large-scale epigenetic studies are still ongoing, and a threshold to define
the minimum DNAmethylation changes able to exert functional significance at the population
level has not yet been firmly established.
To examine the possible functional impact of differential methylation at loci reported there,
we conducted an exploratory analysis using a gene expression/methylation dataset produced
by our group in the context of a previous study [32].
The database comprises paired gene expression and methylation data (whole blood) from
the same subjects and allows methylation/gene expression correlation analyses. Unfortunately,
most of the genes we identified as differentially methylated in this study were only weakly or
not expressed, and only the HELQ gene showed evidence of association between gene expres-
sion and DNA methylation (Spearman correlation, cg01961092 methylation/gene expression
r = -0.26, p = 0.02). Recently, a large-scale genome-wide expression profiling has been
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performed, but none of our differently methylated genes was found to be differentially express-
ed in smokers’ blood cells [33].
We also investigated the relationship between methylation levels and smoking intensity
expressed as pack-year. We observed that in three loci, 2q37.1, EPB41L1, andMYO1G, the meth-
ylation differences between smokers and non-smokers increased according to pack-year, indicat-
ing that these three loci could be further used as epigenetic markers of smoking intensity.
The most enriched GOmolecular functions were all related to GTPase regulatory activity.
Interestingly, the same pathways were identified by analyzing differentially methylated genes
in alveolar macrophages from smokers [23]. Moreover, molecular functions of these genes are
of special interest since a recent study described gene-smoking interactions, identifying several
single nucleotide polymorphisms located in genes belonging to the Rho-GTPase pathway asso-
ciated with an early-onset of coronary artery disease in smokers [34]. Another enriched molec-
ular function was “vitamin D response element binding”. Serum vitamin D levels are inversely
correlated with the incidence, prevalence and death rates of different tumors [35], and recently
Zheng et al. suggested a protective effect of vitamin D against colorectal cancer, whose effects
are more beneficial in active smokers than in non-smokers [36]. Moreover, vitamin D deficien-
cy have been associated with a diminished lung function and more rapid lung function decline
in smokers in a longitudinal cohort of elderly men [37]. These results suggest that vitamin D
may have a protective effect against the damaging effects of smoking on lung function. Smok-
ing has a significant effect on calcium and vitamin D metabolism: the repression of the vitamin
D-parathyroid hormone system, evident among smokers may represent another potential
mechanism for the deleterious effects of smoking on bone metabolism, and may contribute to
the reported risk of osteoporosis among smokers [38].
Conclusions
In this study, we successfully identified 22 DNAmethylation sites that were differentially meth-
ylated. By using MZ twins who were discordant for smoking habits, we were able to replicate
most of the previously published significant sites, with a relatively small number of phenotypi-
cally discordant twin pairs. Moreover, we were also able to detect novel smoking-related differ-
entially methylated CpG sites. Considering both our results along with previously published
results, it is becoming evident that environmental exposures, such as smoking, may modify the
epigenetic profiles of several genes. Given the major burden to individuals and to society of
smoking-related diseases, further functional studies are warranted to better explain the patho-
genic role exerted by smoking through epigenetic changes.
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